Skip to content

5-MeO-DMT: all studies

Page 75 of 110: studies 741 to 750 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

The complete organellar genomes of the entheogenic plant Psychotria viridis (Rubiaceae), a main component of the ayahuasca brew.

PeerJ 2022 Alessandro M Varani, Saura R Silva, Simone Lopes et al. 7 citations

Psychotria viridis (Rubioideae: Rubiaceae), popularly known as chacrona, is commonly found as a shrub in the Amazon region and is well-known to produce psychoactive compounds, such as the N,N-dimethyltryptamine (DMT). Together with the liana Banisteropsis caapi, P. viridis is one of the main components of the Amerindian traditional, entheogenic beverage known as ayahuasca. In this work, we...

DOI: 10.7717/peerj.14114 (opens in new tab) Full text (opens in new tab) Chacrona Chloroplast Comparative genomics Entheogen +8

An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study

Frontiers in Psychology December 16, 2021 Pascal Michael, David Luke, Oliver Robinson 39 citations

Introduction: N,N-dimethyltryptamine (DMT) is an endogenous serotonergic psychedelic capable of producing radical shifts in conscious experience. Increasing trends in its use, as well as new trials administering DMT to patients, indicate the growing importance of a thorough elucidation of the qualitative content, over and above structure, which the drug occasions. This is particularly in light...

DOI: 10.3389/fpsyg.2021.720717 (opens in new tab) Thematic analysis Content measure theory Content analysis Naturalistic observation +7

Psychedelics and Hallucinogens in Psychiatry: Finding New PharmacologicalTargets

Current Topics in Medicinal Chemistry December 2, 2021 Teresa Reynolds de Sousa, João Rema, Sérgio Machado et al. 7 citations

Background: The therapeutic options for neurobehavioral disorders are still limited, and in many cases, they lack a satisfactory balance between efficacy and side effects. Objective: This work aims to review current evidence regarding the potential contribution of psychedelics and hallucinogens to the discovery of new drugs for treating different psychiatric disorders. Discussion:...

Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting

Frontiers in Psychiatry November 5, 2021 Enzo Tagliazucchi, Federico Zamberlán, Federico Cavanna et al. 23 citations

N,N-Dimethyltryptamine (DMT) is a classic psychedelic capable of inducing short-lasting but profound changes in consciousness. As with other psychedelics, the experience induced by DMT strongly depends upon contextual factors, yet the neurobiological determinants of this variability remain unknown. The present study investigated changes in neural oscillations elicited by inhaled DMT, and...

DOI: 10.3389/fpsyt.2021.720066 (opens in new tab) Electroencephalography Consciousness Feeling Audiology +1

Rapid quantification of Psilocybin with reversed-phase HPLC and single-wavelength detection

ChemRxiv October 26, 2021 Alexzander Samuelsson, Eric Janusson, Sajni Shah et al. 2 citations preprint

The alkaloid psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) and the neurologically active psilocin (4-hydroxy-N,N-dimethyltryptamine) are the foremost compounds of pharmaceutical interest in Psilocybe mushrooms. As these compounds are infrequently analyzed in analytical labs, validated methods for rapid purity analysis are lacking. Newfound therapeutic use has invigorated academic and...

DOI: 10.26434/chemrxiv-2021-70mm1 (opens in new tab) Full text (opens in new tab) Psilocybin High-performance liquid chromatography Hallucinogen Pharmacology +1

O Uso da Ayahuasca como terapia alternativa na depressão: efeitos farmacológicos e adversos

Brazilian Journal of Natural Sciences October 12, 2021 Beatriz Souza Silva, Giovanna Pereira Lima, Isabela Rodrigues Alencar Dos Santos et al. 2 citations

Doença comum atualmente, a depressão, quando diagnosticada, é tratada com fármacos antidepressivos, sendo os inibidores seletivos da receptação de serotonina (ISRSs) considerados os de primeira escolha. Tanto esta quanto as demais classes de antidepressivos costumam apresentar efeitos adversos, que muitas vezes levam ao abandono do tratamento pelo paciente. Um outro desafio no tratamento da...

DOI: 10.31415/bjns.v4i2.143 (opens in new tab) Pharmacology Traditional medicine

Novel antidepressant drugs: Beyond monoamine targets

CNS Spectrums September 30, 2021 Xénia Gonda, Péter Döme, Joanna C. Neill et al. 77 citations

Abstract Treatment of major depressive disorder (MDD) including treatment-resistant depression (TRD) remains a major unmet need. Although there are several classes of dissimilar antidepressant drugs approved for MDD, the current drugs have either limited efficacy or are associated with undesirable side effects and withdrawal symptoms. The efficacy and side effects of antidepressant drugs are...

DOI: 10.1017/s1092852921000791 (opens in new tab) Major depressive disorder Antidepressant Monoamine neurotransmitter Tolerability +2

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics

TIPS - Trends in Pharmacological Sciences September 24, 2021 Lily R. Aleksandrova, Anthony G. Phillips 255 citations

The emerging therapeutic efficacy of ketamine and classical psychedelics for depression has inspired tremendous interest in the underlying neurobiological mechanisms. We review preclinical and clinical evidence supporting neuroplasticity as a convergent downstream mechanism of action for these novel fast-acting antidepressants. Through their primary glutamate or serotonin receptor targets,...

New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances

European Psychologist September 17, 2021 Matthias Forstmann, Christina Sagioglou 6 citations

Abstract. After decades of stagnation, research on psychedelic substances (such as lysergic acid diethylamide [LSD], psilocybin, or N,N-dimethyltryptamine [DMT]) has experienced a renaissance over the last 10 years, with various major research programs being conducted across Europe and the United States. This research primarily investigates the potential of psychedelics in the treatment of...

In Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages

Molecules September 13, 2021 Joana Gonçalves, Miguel Castilho, Tiago Rosado et al. 9 citations

Ayahuasca is a psychoactive beverage that contains the psychoactive compound N,N-dimethyltryptamine and β-carboline alkaloids. This study aims at determining in vitro the bioavailability and bioaccessibility of the main compounds present in decoctions of four individual plants, in a commercial mixture and in four mixtures of two individual plants used in the preparation of Ayahuasca. The...

DOI: 10.3390/molecules26185555 (opens in new tab) Bioavailability Cytotoxicity Chromatography Incubation +1